The IDF Diabetes Atlas is intended to support the diabetes community in advocating for more action to identify undiagnosed diabetes, prevent type 2 diabetes in people at risk, and improve care for all people with diabetes. It also aims to support the development of high quality diabetes data in all countries and territories, in order to fill the gaps in knowledge that currently exist.
The 10th edition of the IDF Diabetes Atlas reports a continued global increase in diabetes prevalence, confirming diabetes as a significant global challenge to the health and well-being of individuals, families and societies.
Last updated by source: 2021-11-08
Dataset type: | Time-Series |
Dataset level: | Country |
(International Diabetes
Federation, 2021)
Proportion of total deaths due to diabetes before the age of 60 years, expressed as a percentage.
More about this variableAge-adjusted comparative diabetes prevalence (%) in adults 20–79 years.
More about this variableProjected age-adjusted diabetes prevalence (%) among adults aged 20–79 for the year 2030.
More about this variableProjected age-adjusted diabetes prevalence (%) among adults aged 20–79 for the year 2045.
More about this variableProjected per capita diabetes-related health expenditure (USD) for 2030.
More about this variableProjected per capita diabetes-related health expenditure (USD) for 2030.
More about this variableProjected per capita diabetes-related health expenditure (USD) for 2045.
More about this variableAge-adjusted comparative prevalence of impaired fasting glucose (IFG) (%) among individuals aged 20–79.
More about this variableProjected age-adjusted prevalence of impaired fasting glucose (IFG) (%) among individuals aged 20–79 for 2030.
More about this variableProjected age-adjusted prevalence of impaired fasting glucose (IFG) (%) among individuals aged 20–79 for 2045.
More about this variableAge-adjusted comparative prevalence of impaired glucose tolerance (IGT) among individuals aged 20–79, expressed as a percentage.
More about this variableProjected age-adjusted prevalence of impaired glucose tolerance (IGT) among individuals aged 20–79 for 2030, expressed as a percentage.
More about this variableProjected age-adjusted prevalence of impaired glucose tolerance (IGT) among individuals aged 20–79 for 2045, expressed as a percentage.
More about this variableProportion of individuals aged 20–79 with undiagnosed diabetes, expressed as a percentage.
More about this variable